3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
3
Wilms Tumor
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Xanthogranuloma, Juvenile
1
Thyroid Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Pheochromocytoma
1
Melanoma
1
Histiocytic Sarcoma
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Central Nervous System Neoplasms
1
Interventions
Temozolomide
10
Radiotherapy
5
Radiation
4
Magnetic Resonance Spectroscopy
4
Ipilimumab
3
pembrolizumab
2
Specimen Handling
2
Photons
2
Nivolumab
2
veliparib
1
sargramostim
1
peposertib
1
montanide ISA 51
1
liposomal doxorubicin
1
cemiplimab
1
balstilimab
1
abexinostat
1
X-Rays
1
Vorinostat
1
Utrogestan
1
Surgical Procedures, Operative
1
Sonication
1
Progestins
1
Progesterone
1
Perfusion Magnetic Resonance Imaging
1
Mycophenolic Acid
1
Lomustine
1
Irinotecan
1
Drug Therapy
1
Contrast Media
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gliosarcoma
×
tipifarnib
×
90 days
×
Clear all
No trials found.